On Demand Education

      Test
      Focus Area
      Format
      Evidence
FILTER BY TESTS
DecisionDx-Melanoma DecisionDx-SCC MyPath Melanoma TissueCypher DecisionDx-UM IDgenetix

Enhanced Metastatic Risk Assessment in Cutaneous Squamous Cell Carcinoma with the 40-Gene Expression Profile Test: An Interview with the Lead Author of DecisionDx-SCC’s Validation Study

Sherrif F. Ibrahim, MD, PhD

Cutaneous Squamous Cell Carcinoma DecisionDx-SCC
View Link icon

Maui Derm DecisionDx-SCC Product Theater: Identifying the Risk of Metastasis in cSCC Patients with One or More Risk Factors

Brent Moody, MD, FACP, FAAD

Cutaneous Squamous Cell Carcinoma DecisionDx-SCC
View Link icon

AHNS DecisionDx–SCC Webinar: Identifying the Risk of Metastasis in cSCC and cSCC-HN Patients

Jason Newman, MD, FACS

Cutaneous Squamous Cell Carcinoma DecisionDx-SCC
View Link icon

Mohs Certifying Exam Review 2022

Brent Moody, MD, FACP, FAAD, Michael B. Morgan, MD,

Cutaneous Squamous Cell Carcinoma DecisionDx-SCC
View Link icon

Incorporating Prognostic Gene Expression Profiling in the Management of Skin Cancer

Sep 2021

Drs. Trotter and Sligh hosted a live Q&A session on the content discussed in this webinar. Register for free to be part of the webinar.

This activity has been developed to meet the educational needs of dermatologists, nurse practitioners, physician assistants, and staff who are dedicated to the management of patients with cutaneous melanoma and cutaneous squamous cell carcinoma

Shannon Trotter, DO, Oakview Dermatology, James Sligh, MD, PhD, Bay Pines VA Medical Center

CME/CE: (1.0 AMA PRA Category 1 Credit(s))

Cutaneous Squamous Cell Carcinoma DecisionDx-SCC
View Link icon